Cargando…
Challenges in the Diagnosis and Management of Growth Hormone Deficiency in India
In clinical practice, every year approximately 150,000 children are referred with short stature (SS) based on a cut-off of fifth percentile. The most important endocrine and treatable cause of SS is growth hormone deficiency (GHD). The lack of reliable data on the prevalence of GHD in India limits e...
Autores principales: | John, Mathew, Koledova, Ekaterina, Kumar, Kanakatte Mylariah Prasanna, Chaudhari, Harshal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5102730/ https://www.ncbi.nlm.nih.gov/pubmed/27867396 http://dx.doi.org/10.1155/2016/2967578 |
Ejemplares similares
-
Incidence trends for childhood type 1 diabetes in India
por: Kumar, Kanakatte Mylariah Prasanna
Publicado: (2015) -
Improving diabetes care for children with type 1 diabetes from poor families: Changing diabetes(®) in children program, India
por: Kumar, Kanakatte Mylariah Prasanna
Publicado: (2014) -
Effect of adherence to growth hormone treatment on 0–2 year catch-up growth in children with growth hormone deficiency
por: van Dommelen, Paula, et al.
Publicado: (2018) -
Evolving Landscape of Multiple Sclerosis in India: Challenges in the Management
por: Kumar, Sudhir, et al.
Publicado: (2018) -
Managing Transition in Patients Treated with Growth Hormone
por: Hauffa, Berthold P., et al.
Publicado: (2017)